PDT Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-53,755
| Closed | -$2.91M | – | 568 |
|
|
2025
Q3 | $2.91M | Hold |
53,755
| – | – | 0.18% | 192 |
|
|
2025
Q2 | $2.95M | Sell |
53,755
-22,121
| -29% | -$1.3M | 0.17% | 213 |
|
|
2025
Q1 | $5.36M | Sell |
75,876
-12,787
| -14% | -$860K | 0.38% | 58 |
|
|
2024
Q4 | $5.83M | Buy |
88,663
+55,635
| +168% | +$3.73M | 0.52% | 22 |
|
|
2024
Q3 | $2.32M | Buy |
+33,028
| New | +$2.76M | 0.21% | 170 |
|
|
2023
Q1 | – | Sell |
-11,574
| Closed | -$1.2M | – | 584 |
|
|
2022
Q4 | $1.2M | Sell |
11,574
-182
| -2% | -$17.1K | 0.19% | 186 |
|
|
2022
Q3 | $997K | Buy |
+11,756
| New | +$1.05M | 0.15% | 218 |
|
|
2022
Q2 | – | Sell |
-6,888
| Closed | -$531K | – | 964 |
|
|
2022
Q1 | $531K | Buy |
+6,888
| New | +$576K | 0.05% | 569 |
|
|
2021
Q3 | – | Sell |
-9,323
| Closed | -$778K | – | 778 |
|
|
2021
Q2 | $778K | Buy |
+9,323
| New | +$739K | 0.05% | 419 |
|
|
2019
Q3 | – | Sell |
-298,500
| Closed | -$25.6M | – | 458 |
|
|
2019
Q2 | $25.6M | Buy |
298,500
+23,995
| +9% | +$2.05M | 1.51% | 7 |
|
|
2019
Q1 | $24.4M | Sell |
274,505
-7
| -0% | -$649 | 1.38% | 10 |
|
|
2018
Q4 | $23.4M | Buy |
274,512
+12
| +0% | +$1.14K | 1.31% | 9 |
|
|
2018
Q3 | $26.6M | Sell |
274,500
-92,000
| -25% | -$9.18M | 1.1% | 17 |
|
|
2018
Q2 | $34.5M | Hold |
366,500
| – | – | 1.31% | 4 |
|
|
2018
Q1 | $29.7M | Sell |
366,500
-43
| -0% | -$3.69K | 1% | 13 |
|
|
2017
Q4 | $32.7M | Buy |
366,543
+97,943
| +36% | +$8.52M | 0.95% | 9 |
|
|
2017
Q3 | $25M | Hold |
268,600
| – | – | 0.83% | 18 |
|
|
2017
Q2 | $24.4M | Buy |
+268,600
| New | +$24.4M | 0.98% | 12 |
|
|
2015
Q4 | – | Sell |
-131,909
| Closed | -$13.9M | – | 464 |
|
|
2015
Q3 | $13.9M | Buy |
131,909
+55,991
| +74% | +$7.48M | 0.31% | 84 |
|
|
2015
Q2 | $10.4M | Sell |
75,918
-34,160
| -31% | -$4.23M | 0.27% | 72 |
|
|
2015
Q1 | $13.7M | Buy |
110,078
+99,178
| +910% | +$10.5M | 0.34% | 54 |
|
|
2014
Q4 | $985K | Sell |
10,900
-2,900
| -21% | -$241K | 0.09% | 282 |
|
|
2014
Q3 | $996K | Sell |
13,800
-44,475
| -76% | -$2.92M | 0.03% | 649 |
|
|
2014
Q2 | $3.63M | Buy |
58,275
+46,896
| +412% | +$2.83M | 0.1% | 274 |
|
|
2014
Q1 | $776K | Buy |
11,379
+1,463
| +15% | +$108K | 0.02% | 766 |
|
|
2013
Q4 | $697K | Sell |
9,916
-57,895
| -85% | -$3.93M | 0.08% | 309 |
|
|
2013
Q3 | $4.9M | Buy |
67,811
+7,581
| +13% | +$504K | 0.13% | 190 |
|
|
2013
Q2 | $3.36M | Buy |
+60,230
| New | +$3.75M | 0.08% | 312 |
|
Other funds holding BMRN
